75N93021C00029↗
Seattle Children'S Hospital received this contract from National Institutes of Health Niaid, National Institutes of Health: $35.31M obligated so far for health r&d services; health care services; applied research. It runs to 2027-07-31, or to 2028-07-31 if every option is exercised.
Key facts · data as of Oct 25, 2026
- Recipient
- Seattle Children'S Hospital
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $35.31M
- Potential value
- $48.07M
- Ends
- 2027-07-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N93021C00029, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N93021C00029_7529_-NONE-_-NONE-
Seattle Children'S Hospital: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
Obligated to date$35.31M7 actions
Current value$48.07Mwith options exercised
Period2021-08-01 → 2027-07-31up to 2028-07-31 with options
Passed on$17.32Mto 9 subcontractors
Up for re-bid: ends 2027-07-31. Recompete brief → · 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition · 12 offers received
- Pricing
- Cost no fee
- How it was bought
- Standalone contract
- Solicitation
- BAA-NIAID-NIHAI201700104
- Where the work is
- King, WA · district WA-07
Obligations by fiscal year
FY2023$12.96M
FY2024$11.55M
FY2025$4.90M
FY2026$5.91M
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
34 subawards totaling $17.32M (49.0% of what was obligated), as Seattle Children'S Hospital reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Colorado State University | $7.00M | 9 | CO | 2022-12-31 | 2026-01-12 |
| Uk Health Security Agency | $6.01M | 7 | 2023-04-30 | 2025-10-08 | |
| University of Oxford | $2.12M | 7 | 2022-10-31 | 2025-09-22 | |
| Fred Hutchinson Cancer Center | $725.1K | 3 | WA | 2022-12-31 | 2025-09-10 |
| President and Fellows of Harvard College | $634.1K | 2 | MA | 2025-05-14 | 2025-09-10 |
| Partners Healthcare System, Inc | $451.1K | 1 | MA | 2024-01-31 | 2024-01-31 |
| Denver Research Institute | $227.1K | 2 | CO | 2024-11-30 | 2024-11-30 |
| Statens Serum Institut | $116.0K | 2 | 2025-01-31 | 2025-11-03 | |
| Los Angeles Jolla Institute for Immunology | $30.1K | 1 | CA | 2022-12-31 | 2022-12-31 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2023-12-31 | Colorado State University | $1.87M | PI: HONG QI, QOOLABS INC, 1915 ASTON AVE, CARLSBAD, CA 92008 I. BACKGROUND INFORMATION GUINEA PIGS HAVE BEEN USED AS EXPERIMENTAL ANIMALS FOR CENTURIES. DUE TO THEIR BIOLOGICAL SIMILARITIES TO HUMANS, GUINEA PIGS WERE… |
| 2025-04-01 | Uk Health Security Agency | $1.83M | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT UK HEALTH SECURITY AGENCY (UKHSA), PREVIOUSLY KNOWN AS PUBLIC HEALTH ENGLAND (PHE), WILL BE PERFORMING. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING… |
| 2024-07-25 | Uk Health Security Agency | $1.43M | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NONTUBERCULOUS MYCOBACTERIA (NTM) INTERFERENCE, RNA DELIVERY,… |
| 2024-11-30 | Colorado State University | $1.41M | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT COLORADO STATE UNIVERSITY (CSU) WILL BE PERFORMING THROUGHOUT THE PROPOSED WORK PERIOD. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF THE OVERALL… |
| 2023-04-30 | Uk Health Security Agency | $1.19M | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2026-01-12 | Colorado State University | $1.13M | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NONTUBERCULOUS MYCOBACTERIA (NTM) INTERFERENCE, RNA VACCINE… |
| 2022-12-31 | Colorado State University | $902.3K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2024-05-31 | Colorado State University | $899.8K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2025-04-01 | Uk Health Security Agency | $652.2K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT UK HEALTH SECURITY AGENCY (UKHSA), PREVIOUSLY KNOWN AS PUBLIC HEALTH ENGLAND (PHE), WILL BE PERFORMING. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING… |
| 2025-09-10 | President and Fellows of Harvard College | $573.2K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2025-10-08 | Uk Health Security Agency | $551.4K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT UK HEALTH SECURITY AGENCY (UKHSA), PREVIOUSLY KNOWN AS PUBLIC HEALTH ENGLAND (PHE), WILL BE PERFORMING. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING… |
| 2025-09-10 | Fred Hutchinson Cancer Center | $456.6K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT FRED HUTCHINSON CANCER CENTER (FHCC) WILL BE PERFORMING. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF THE OVERALL ACTIVITIES IN THE PRIME CONTRACT.… |
| 2024-01-31 | The General Hospital Corporation | $451.1K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2023-06-30 | University of Oxford | $448.2K | OPTION 4 ACTIVITIES: CONDUCT TWO PHASE 1 CLINICAL TRIALS IN THE CONTROLLED HUMAN MYCOBACTERIAL CHALLENGE MODEL USING AN ESTABLISHED MODEL OF AEROSOLIZED BCG DELIVERED TO THE LUNGS OF HUMANS, FOLLOWED BY BRONCHOSCOPIC… |
| 2024-11-30 | Colorado State University | $424.0K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT COLORADO STATE UNIVERSITY (CSU) WILL BE PERFORMING THROUGHOUT THE PROPOSED WORK PERIOD. THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF ACTIVITIES IN THE… |
| 2025-01-31 | University of Oxford | $420.8K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT OXFORD UNIVERSITY WILL BE PERFORMING THROUGHOUT THE PROPOSED TOTAL WORK PERIOD. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF THE OVERALL ACTIVITIES… |
| 2024-02-29 | University of Oxford | $396.3K | OPTION 4 ACTIVITIES: CONDUCT TWO PHASE 1 CLINICAL TRIALS IN THE CONTROLLED HUMAN MYCOBACTERIAL CHALLENGE MODEL USING AN ESTABLISHED MODEL OF AEROSOLIZED BCG DELIVERED TO THE LUNGS OF HUMANS, FOLLOWED BY BRONCHOSCOPIC… |
| 2022-10-31 | University of Oxford | $366.0K | OPTION 4 ACTIVITIES: CONDUCT TWO PHASE 1 CLINICAL TRIALS IN THE CONTROLLED HUMAN MYCOBACTERIAL CHALLENGE MODEL USING AN ESTABLISHED MODEL OF AEROSOLIZED BCG DELIVERED TO THE LUNGS OF HUMANS, FOLLOWED BY BRONCHOSCOPIC… |
| 2023-05-31 | Colorado State University | $315.2K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2024-11-30 | University of Oxford | $254.1K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT THE UNIVERSITY OF OXFORD (LEGAL ENTITY THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD) WILL BE PERFORMING THROUGHOUT THE PROPOSED TOTAL WORK… |
| 2024-11-30 | Fred Hutchinson Cancer Center | $237.1K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT FRED HUTCHINSON CANCER CENTER (FHCC) WILL BE PERFORMING. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF THE OVERALL ACTIVITIES IN THE PRIME CONTRACT.… |
| 2025-09-22 | University of Oxford | $205.3K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT OXFORD UNIVERSITY WILL BE PERFORMING THROUGHOUT THE PROPOSED TOTAL WORK PERIOD. NOTE THAT THE TASK NUMBERS BELOW REFLECT THE NUMBERING OF THE OVERALL ACTIVITIES… |
| 2024-07-29 | Uk Health Security Agency | $199.1K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NONTUBERCULOUS MYCOBACTERIA (NTM) INTERFERENCE, RNA DELIVERY,… |
| 2023-04-30 | Uk Health Security Agency | $154.8K | THROUGH THE EXECUTION OF THIS CONTRACT, WE WILL EXAMINE BASIC INDUCTION OF INNATE AND ADAPTIVE IMMUNITY FROM VACCINATION, INCLUDING STUDIES THAT ADDRESS NTM INTERFERENCE, RNA DELIVERY, PRIME-BOOST REGIMENS (INCLUDING… |
| 2024-11-30 | Denver Research Institute | $136.4K | THIS STATEMENT OF WORK (SOW) OUTLINES THE ACTIVITIES THAT THE SITES €€Œ DENVER RESEARCH INSTITUTE (AKA DRI, ADMINISTRATIVE/SUBCONTRACT SITE) AND ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER (AKA RMR-VAMC,… |
Every action
7 actions since 2023-07-24. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-30 | P00015 | Option exercised | $5.91M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2026-07-28 | P00014 | Administrative change | $0 | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2025-07-14 | P00013 | Option exercised | $4.90M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2024-09-11 | P00012 | Funding only | $2.01M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2024-07-29 | P00011 | Option exercised | $9.54M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2023-09-14 | P00010 | Change order | $2.11M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
| 2023-07-24 | P00009 | Option exercised | $10.84M | IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗